Clinical and prognostic aspects in hypersensitivity pneumonitis

Capră, Dumitru; Calaraș, Diana

dc.contributor.author	Capră, Dumitru
dc.contributor.author	Calaraș, Diana
dc.date.accessioned	2022-11-08T11:43:34Z
dc.date.available	2022-11-08T11:43:34Z
dc.date.issued	2022
dc.identifier.citation	CAPRĂ, Dumitru , CALARAȘ, Diana. Clinical and prognostic aspects in hypersensitivity pneumonitis: [poster]. In: Conferinţa ştiinţifică anuală "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță", 19-21 octombrie 2022: culegere de postere electronice. 2022, p. 82.	en_US
dc.identifier.uri	https://conferinta.usmf.md/wp-content/uploads/culegere_de_postere_2022.pdf
dc.identifier.uri	https://repository.usmf.md/handle/20.500.12710/22222
dc.description.abstract	Introduction.Hypersensitivity pneumonitis (HP) is a type of interstitial lung disease that occurs following sensitization to an inhaled organic antigen. Although previously classified as acute, subacute and chronic, this classification has not proven to be a good prognostic tool. Therefore, lately the use of fibrotic hypersensitivity pneumonitis (FHP) and nonfibrotic hypersensitivity pneumonitis (NFHP) classification is recommended. Purpose. To study the differences in clinical, diagnostic and prognostic features in patients with fibrotic and nonfibrotic hypersensitivity pneumonitis. Material and methods. We have identified 39 patients, with mean age 47 ± 15 years diagnosed with HP in Chiril Draganiuc Institute of Phtisiopneumology during 2017-2021. Patiens were were analyzed by: antigen exposure history, imaging data, bronchoalveolar lavage (BAL), functional respiratory tests.	en_US
dc.language.iso	en	en_US
dc.publisher	Universitatea de Stat de Medicină şi Farmacie "Nicolae Testemiţanu" din Republica Moldova	en_US
dc.relation.ispartof	Conferinţa ştiinţifică anuală "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță", 2022	en_US
dc.title	Clinical and prognostic aspects in hypersensitivity pneumonitis	en_US
dc.type	Other	en_US